Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-07 9:37 pm Purchase | 2025-03-27 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 80,410 13.300% | 80,410 (New Position) | Filing History |
| 2025-04-03 6:00 pm Purchase | 2025-03-27 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 80,410 7.800% | 35 (+0.04%) | Filing History |
| 2025-02-13 6:00 pm Unchanged | 2025-01-24 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 80,375 15.000% | 0 (Unchanged) | Filing History |
| 2025-01-23 9:54 pm Purchase | 2025-01-21 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 80,375 16.000% | 78,825 (+5084.05%) | Filing History |
| 2023-03-30 4:06 pm Purchase | 2023-03-20 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 1,554 9.600% | 1,554 (New Position) | Filing History |
| 2023-01-18 5:01 pm Purchase | 2022-08-12 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 1,550 28.900% | 26 (+1.71%) | Filing History |
| 2022-05-05 5:00 pm Purchase | 2022-04-25 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 1,524 37.700% | 136 (+9.82%) | Filing History |
| 2021-08-27 5:00 pm Purchase | 2021-08-17 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 1,388 39.200% | 1,388 (New Position) | Filing History |